Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas

L F Brown, B Berse, R W Jackman, K Tognazzi, E J Manseau, H F Dvorak, D R Senger, L F Brown, B Berse, R W Jackman, K Tognazzi, E J Manseau, H F Dvorak, D R Senger

Abstract

Vascular permeability factor (VPF), also known as vascular endothelial growth factor, is a secreted protein implicated in tumor-associated microvascular hyperpermeability and angiogenesis. Tumor cells in 11 of 12 renal cell carcinomas expressed high levels of VPF messenger RNA (mRNA) by in situ hybridization, the only exception being a case of the relatively avascular papillary variant. Expression was further accentuated adjacent to areas of necrosis. Both tumor cells and endothelial cells in small vessels adjacent to tumor stained strongly for VPF protein by immunohistochemistry. Endothelial cells did not express detectable VPF mRNA, but did express high levels of mRNA for the VPF receptors flt-1 and KDR indicating that the endothelial cell staining likely reflects binding of VPF secreted by adjacent tumor cells. Three transitional cell carcinomas also labeled strongly for VPF mRNA. These data suggest an important role for VPF in the vascular biology of these two common human malignancies.

References

    1. Biochem Biophys Res Commun. 1989 Jun 15;161(2):851-8
    1. J Immunol. 1988 Apr 1;140(7):2340-9
    1. J Clin Invest. 1989 Nov;84(5):1470-8
    1. J Biol Chem. 1989 Nov 25;264(33):20017-24
    1. Science. 1989 Dec 8;246(4935):1306-9
    1. Science. 1989 Dec 8;246(4935):1309-12
    1. Cancer Res. 1990 Mar 15;50(6):1774-8
    1. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2628-32
    1. J Exp Med. 1990 Dec 1;172(6):1535-45
    1. Am J Pathol. 1991 Jan;138(1):213-21
    1. J Biol Chem. 1991 Jun 25;266(18):11947-54
    1. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5819-23
    1. Oncogene. 1991 Sep;6(9):1677-83
    1. J Exp Med. 1991 Nov 1;174(5):1275-8
    1. Biochem Biophys Res Commun. 1991 Dec 16;181(2):902-6
    1. Mol Endocrinol. 1991 Dec;5(12):1806-14
    1. Science. 1992 Feb 21;255(5047):989-91
    1. Mol Biol Cell. 1992 Feb;3(2):211-20
    1. J Biol Chem. 1992 Jun 5;267(16):10931-4
    1. J Exp Med. 1992 Nov 1;176(5):1375-9
    1. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1579-86
    1. Nature. 1992 Oct 29;359(6398):843-5
    1. Nature. 1992 Oct 29;359(6398):845-8
    1. J Cell Physiol. 1992 Dec;153(3):557-62
    1. J Biol Chem. 1992 Dec 25;267(36):26031-7
    1. Cancer Res. 1993 Jan 1;53(1):153-7
    1. Kidney Int. 1992 Dec;42(6):1457-61
    1. J Clin Invest. 1993 Jan;91(1):153-9
    1. Am J Pathol. 1993 Jan;142(1):273-83
    1. Arch Biochem Biophys. 1993 Feb 15;301(1):15-20
    1. Nature. 1993 Apr 29;362(6423):841-4
    1. Cancer. 1976 Dec;38(6):2469-80
    1. J Immunol. 1979 Jan;122(1):166-74
    1. Ann N Y Acad Sci. 1978 Jun 20;312:38-42
    1. Urology. 1979 Nov;14(5):491-5
    1. Science. 1983 Feb 25;219(4587):983-5
    1. Cancer Res. 1986 Nov;46(11):5629-32
    1. Lab Invest. 1987 Dec;57(6):673-86
    1. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7311-5

Source: PubMed

3
Suscribir